Day: July 5, 2025

Personalized Ketamine Regimens: Leveraging Biomarkers for Optimized Outcomes

Introduction Ketamine, a dissociative anesthetic, has emerged as a promising treatment for various mental health conditions, notably treatment-resistant depression (TRD).  However, the efficacy of ketamine varies significantly between individuals.  While some experience substantial remission, others show minimal response. Says Dr. Austin Harris this variability highlights the crucial need for personalized treatment approaches, moving beyond a “one-size-fits-all” […]